<DOC>
	<DOCNO>NCT01986127</DOCNO>
	<brief_summary>We study administration intralesional Adalimumab ( directly inject stricture ) associate endoscopic dilatation high success rate week 8 compare placebo patient Crohn 's disease confirm intestinal stenosis ( 3 stenosis maximum )</brief_summary>
	<brief_title>Adalimumab Intralesional Intestinal Strictures Crohn 's Disease Patients</brief_title>
	<detailed_description />
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Constriction , Pathologic</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<criteria>Patients sex old 18 year Patient diagnose CROHNÂ´s disease Patient intestinal stenosis length equal le 5cm previously confirm bowel magnetic resonance imaging ( 3 stenosis maximum ) Stenosis permeable endoscopy ( 12mm case accessible stenosis conventional colonoscopy 10mm case accessible stenosis balloon enteroscopy ) Dilated stenosis accord endoscopist criterion ( pas endoscopy ) Patient capable participate examination require study Patient inform , give his/her informed consent write Patients large intestinal stenosis ( 6cm ) multiple Patients previous actual treatment antitumor necrosis factor ( antiTNF ) drug Patients positive serology hepatitis B virus ( HBV ) , hepatitis C virus ( HCV ) , HIV Patients positive screening Tuberculosis ( positive PPD ) Established contraindication antiTNF drug Existence fistulous tract associate intestinal stenosis Neoplastic process associate stenosis another location Pregnancy breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Crohn disease</keyword>
</DOC>